Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;39(11):1439-1441.
doi: 10.1038/s41372-019-0518-3. Epub 2019 Oct 7.

Pharmacological closure of the patent ductus arteriosus: when treatment still makes sense

Affiliations

Pharmacological closure of the patent ductus arteriosus: when treatment still makes sense

Maria Gillam-Krakauer et al. J Perinatol. 2019 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Superimposed trends in treatment with cyclooxygenase inhibitors (COX-I) in preterm infants, 2008–2015, and potential impact on survival in infants 400–749 g birth weight [14]. ‘Observed’ = observed average of 55 NICU-specific unadjusted mortality rates, infants born 400–749 g, CPQCC. ‘Estimated’ = estimated average NICU-specific unadjusted mortality rate, infants born 400–749 g, with COX-I use sustained at 2008–2009 baseline (data sub-analysis derived from [14]). *Treatment rate among infants diagnosed with PDA converted to all infants meeting study inclusion criteria using reported yearly rate of PDA diagnosis

References

    1. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001; 344:1966–72. - PubMed
    1. Ngo S, Profit J, Gould JB, Lee HC. Trends in patent ductus arteriosus diagnosis and management for very low birth weight infants. Pediatrics. 2017;139:e20162390. - PMC - PubMed
    1. Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units. J Pediatr. 2017;189:105–12. - PubMed
    1. Hagadorn JI, Brownell EA, Trzaski JM, Johnson KR, Lainwala S, Campbell BT, et al. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus. Pediatr Res. 2016;80:785–92. - PubMed
    1. Lokku A, Mirea L, Lee SK, Shah PS, Canadian Neonatal N. Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol. 2017;34:441–50. - PubMed

Publication types